|
Delayed
London S.E.
05:51:57 2026-10-21 EDT
|
5-day change | 1st Jan Change | ||
| 1.049 GBX | -2.46% |
|
-0.13% | +19.84% |
| 10-12 | Tialis wins "significant" utilities contract | AN |
| 10-12 | Genedrive PLC Notes NIHR Case Study On Development, Clinical Validation And Adoption Of Genedrive MT-RNR1 ID Kit | CI |
Company Valuation: genedrive plc
Data adjusted to current consolidation scope
| Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 53.01 | 35.61 | 16.19 | 17.33 | 8.962 | 8.749 |
| Change | - | -32.82% | -54.52% | 7.04% | -48.3% | -2.38% |
| Enterprise Value (EV) 1 | 56.39 | 33.15 | 11.62 | 14.97 | 3.793 | 7.567 |
| Change | - | -41.21% | -64.95% | 28.85% | -74.67% | 99.5% |
| P/E | -1.85x | -46.9x | -3.18x | -3.18x | -0.35x | -1.51x |
| PBR | -15.9x | 9.92x | 2.89x | 8.49x | 1.67x | 6.08x |
| PEG | - | 0.5x | -0x | 19.25x | 0x | 0x |
| Capitalization / Revenue | 50.1x | 51.8x | 330x | 315x | 17.9x | 9.17x |
| EV / Revenue | 53.2x | 48.3x | 237x | 272x | 7.57x | 7.93x |
| EV / EBITDA | -10.1x | -6.11x | -2.09x | -2.9x | -0.72x | -1.42x |
| EV / EBIT | -10x | -6.05x | -2.07x | -2.87x | -0.71x | -1.41x |
| EV / FCF | -17.2x | -7.61x | -3.48x | -10.4x | -1x | -2.26x |
| FCF Yield | -5.83% | -13.1% | -28.7% | -9.64% | -99.6% | -44.2% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.55 | -0.012 | -0.0551 | -0.055 | -0.047 | -0.009293 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 1.059 | 0.687 | 0.049 | 0.055 | 0.501 | 0.954 |
| EBITDA 1 | -5.583 | -5.422 | -5.552 | -5.163 | -5.258 | -5.33 |
| EBIT 1 | -5.64 | -5.482 | -5.615 | -5.224 | -5.312 | -5.38 |
| Net income 1 | -19.42 | -0.691 | -4.675 | -5.15 | -7.075 | -5.231 |
| Net Debt 1 | 3.381 | -2.455 | -4.573 | -2.36 | -5.169 | -1.182 |
| Reference price 2 | 1.0200 | 0.5625 | 0.1750 | 0.1750 | 0.0165 | 0.0140 |
| Nbr of stocks (in thousands) | 51,967 | 63,302 | 92,535 | 99,050 | 543,141 | 624,895 |
| Announcement Date | 11/27/20 | 11/16/21 | 12/5/22 | 12/6/23 | 12/5/24 | 12/8/25 |
1GBP in Million2GBP
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 23.09M | |
| 34.14x | 5.97x | 22.85x | 0.27% | 254B | |
| 38.16x | 6.76x | 21.41x | 0.64% | 158B | |
| 46.54x | 12.6x | 27.78x | -.--% | 155B | |
| 17.13x | 3.42x | 11.17x | -.--% | 66.06B | |
| 48.79x | 12.07x | 26.6x | -.--% | 51.6B | |
| 20.29x | 2.44x | 12.32x | 2.49% | 51.82B | |
| 35.51x | 6.99x | 22.18x | -.--% | 50.89B | |
| 33.71x | 6.67x | 22.63x | 0.59% | 48.78B | |
| 77.52x | 7.39x | 22.48x | -.--% | 43.51B | |
| Average | 39.09x | 7.15x | 21.05x | 0.44% | 87.92B | |
| Weighted average by Cap. | 38.01x | 7.41x | 22.11x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EHP Stock
- Valuation genedrive plc
Select your edition
All financial news and data tailored to specific country editions
